[해외논문]
Elevated expression of SAG/ROC2/Rbx2/Hrt2 in human colon carcinomas: SAG does not induce neoplastic transformation, but antisense SAG transfection inhibits tumor cell growth
Molecular carcinogenesis ,
v.30 no.1 ,
2001년, pp.62 - 70
Huang, Yuanhui
(Department of Molecular Biology, Pfizer Global Research and Development, Ann Arbor Laboratories, Ann Arbor, Michigan)
,
Duan, Hangjun
(Department of Molecular Biology, Pfizer Global Research and Development, Ann Arbor Laboratories, Ann Arbor, Michigan)
,
Sun, Yi
(Department of Molecular Biology, Pfizer Global Research and Development, Ann Arbor Laboratories, Ann Arbor, Michigan)
Sensitive-to-apoptosis gene (SAG)/regulator of cullins (ROC)2/Rbx2/Hrt2 is a newly identified component of SCF E3 ubiquitin ligase that controls cell-cycle progression by promoting ubiquitination and degradation of cell-cycle inhibitors. We recently found that SAG protects cells from apoptosis induc...
Sensitive-to-apoptosis gene (SAG)/regulator of cullins (ROC)2/Rbx2/Hrt2 is a newly identified component of SCF E3 ubiquitin ligase that controls cell-cycle progression by promoting ubiquitination and degradation of cell-cycle inhibitors. We recently found that SAG protects cells from apoptosis induced by redox agents, promotes S-phase entry and cell growth under serum starvation, and is required for yeast growth. In the present study, we report that the SAG protein level was elevated in six of 10 human colon carcinoma tissues (60%) as compared with adjacent normal tissues from the same patient. SAG overexpression in preneoplastic cells in a JB6 tumor promotion-and-progression model did not induce neoplastic transformation, and SAG overexpression in NIH/3T3 cells did not induce transforming foci formation, suggesting that SAG is not a dominant oncogene. However, when DLD-1 human colon carcinoma cells were transfected with antisense SAG, monolayer growth was significantly inhibited, as shown by a decreased number of stable colonies in the plate after normalization with transfection efficiency. Stable clones that expressed antisense SAG showed a 50% decrease in their ability to form colonies when grown in soft agar versus clones that did not express antisense SAG. We found an inverse correlation in four of 10 tumors between the levels of SAG and p27, a cyclin-dependent kinase inhibitor. We concluded that SAG is not causally related to cellular transformation, but its overexpression may be important for the maintenance of tumor cell phenotype. Therefore, targeting SAG expression may have therapeutic value in cancer treatment. Mol. Carcinog. 30:62–70, 2001. © 2001 Wiley-Liss, Inc.
Sensitive-to-apoptosis gene (SAG)/regulator of cullins (ROC)2/Rbx2/Hrt2 is a newly identified component of SCF E3 ubiquitin ligase that controls cell-cycle progression by promoting ubiquitination and degradation of cell-cycle inhibitors. We recently found that SAG protects cells from apoptosis induced by redox agents, promotes S-phase entry and cell growth under serum starvation, and is required for yeast growth. In the present study, we report that the SAG protein level was elevated in six of 10 human colon carcinoma tissues (60%) as compared with adjacent normal tissues from the same patient. SAG overexpression in preneoplastic cells in a JB6 tumor promotion-and-progression model did not induce neoplastic transformation, and SAG overexpression in NIH/3T3 cells did not induce transforming foci formation, suggesting that SAG is not a dominant oncogene. However, when DLD-1 human colon carcinoma cells were transfected with antisense SAG, monolayer growth was significantly inhibited, as shown by a decreased number of stable colonies in the plate after normalization with transfection efficiency. Stable clones that expressed antisense SAG showed a 50% decrease in their ability to form colonies when grown in soft agar versus clones that did not express antisense SAG. We found an inverse correlation in four of 10 tumors between the levels of SAG and p27, a cyclin-dependent kinase inhibitor. We concluded that SAG is not causally related to cellular transformation, but its overexpression may be important for the maintenance of tumor cell phenotype. Therefore, targeting SAG expression may have therapeutic value in cancer treatment. Mol. Carcinog. 30:62–70, 2001. © 2001 Wiley-Liss, Inc.
Keyword
참고문헌 (35)
Cell Hunter 79 573 1994 10.1016/0092-8674(94)90543-6
Science Weinberg 230 770 1985 10.1126/science.2997917
Cell Fearon 61 759 1990 10.1016/0092-8674(90)90186-I
Science Hartwell 266 1821 1994 10.1126/science.7997877
Genes Dev Sherr 9 1149 1995 10.1101/gad.9.10.1149
Science King 274 1652 1996 10.1126/science.274.5293.1652
J Mol Med Rolfe 75 5 1997 10.1007/s001090050081
EMBO J Ciechanover 17 7151 1998 10.1093/emboj/17.24.7151
Mol Cell Biol Duan 19 3145 1999 10.1128/MCB.19.4.3145
Free Radicals Biol Med Swaroop 27 193 1999 10.1016/S0891-5849(99)00078-7
Oncogene Swaroop 19 2855 2000 10.1038/sj.onc.1203635
Science Kamura 284 657 1999 10.1126/science.284.5414.657
Mol Cell Ohta 3 535 1999 10.1016/S1097-2765(00)80482-7
Mol Cell Tan 3 527 1999 10.1016/S1097-2765(00)80481-5
Genes Dev Seol 13 1614 1999 10.1101/gad.13.12.1614
Mol Carcinog Duan 30 37 2000 10.1002/1098-2744(200101)30:1<37::AID-MC1011>3.0.CO;2-7
Proc Natl Acad Sci USA Sun 90 2827 1993 10.1073/pnas.90.7.2827
Cancer Res Sun 52 1907 1992
Mol Carcinog Sun 8 49 1993 10.1002/mc.2940080111
Carcinogenesis Sun 20 1899 1999 10.1093/carcin/20.10.1899
Nature Yuspa 262 402 1976 10.1038/262402a0
J Cell Biochem Colburn 18 261 1982 10.1002/jcb.1982.240180302
Cell Bai 86 263 1996 10.1016/S0092-8674(00)80098-7
Cell Skowyra 91 209 1997 10.1016/S0092-8674(00)80403-1
Genes Dev Montagnoli 13 1181 1999 10.1101/gad.13.9.1181
Curr Biol Tsvetkov 9 661 1999 10.1016/S0960-9822(99)80290-5
Nat Cell Biol Carrano 1 193 1999 10.1038/12013
Nat Cell Biol Sutterluty 1 207 1999 10.1038/12027
Nat Med Catzavelos 3 227 1997 10.1038/nm0297-227
Cancer Res Catzavelos 59 684 1999
Nat Med Loda 3 231 1997 10.1038/nm0297-231
Oncogene Ohta 18 6758 1999 10.1038/sj.onc.1203115
Cancer Res Chen 58 3677 1998
Cell Zhang 82 915 1995 10.1016/0092-8674(95)90271-6
Science Pagano 269 682 1995 10.1126/science.7624798
더보기
AI-Helper
※ AI-Helper는 부적절한 답변을 할 수 있습니다.